These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Indication for a modern therapy of rheumatoid arthritis]. Pappalardo A; Compagno M Clin Ter; 1998; 149(2):135-8. PubMed ID: 9780479 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of slow-acting drugs in rheumatoid arthritis. Lipsky PE Clin Exp Rheumatol; 1989; 7 Suppl 3():S177-80. PubMed ID: 2575024 [TBL] [Abstract][Full Text] [Related]
5. The management of inflammation in rheumatic diseases. Currey HL S Afr Med J; 1978 Aug; 54(8):309-14. PubMed ID: 31004 [TBL] [Abstract][Full Text] [Related]
6. The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis. Hart LE; Tugwell P Postgrad Med J; 1989 Dec; 65(770):905-12. PubMed ID: 2694146 [No Abstract] [Full Text] [Related]
7. Rheumatoid nodules do not predict response to treatment with slow-acting anti-rheumatic drugs. Hall GM; Studnicke A; Huskisson EC; Scott DL Clin Rheumatol; 1991 Dec; 10(4):384-7. PubMed ID: 1802492 [TBL] [Abstract][Full Text] [Related]
9. Slow acting antirheumatic drugs in rheumatoid arthritis. Gow PJ N Z Med J; 1993 Mar; 106(951):85-7. PubMed ID: 8474708 [No Abstract] [Full Text] [Related]
10. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Voulgari PV Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280 [TBL] [Abstract][Full Text] [Related]
11. [The role of neutrophils in the pathogenesis of rheumatoid arthritis and their changes as affected by anti-rheumatic agents]. Malinovskaia EI Revmatologiia (Mosk); 1988; (2):63-8. PubMed ID: 3051279 [No Abstract] [Full Text] [Related]
12. The rheumatological disease process. Inflammation, immunology, and non-steroidal anti-inflammatory drugs. Proceedings of an international symposium. London, England, April 28-29, 1983. Inflammation; 1984 Jun; 8 Suppl():S1-154. PubMed ID: 6480067 [No Abstract] [Full Text] [Related]
13. Regulation of myeloid development and function by colony stimulating factors. Barreda DR; Hanington PC; Belosevic M Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis. Kontny E; Maśliński W; Marcinkiewicz J Adv Exp Med Biol; 2003; 526():329-40. PubMed ID: 12908617 [No Abstract] [Full Text] [Related]
18. [Drug therapy of rheumatoid arthritis. Recommendations to specialists and general practitioners]. Glennås A; Ostensen M Tidsskr Nor Laegeforen; 1994 Jan; 114(2):185-6. PubMed ID: 8122200 [TBL] [Abstract][Full Text] [Related]
19. Aspects of the clinical trials of slow-acting anti-rheumatic drugs. Day RO; Breit SN; Cairns D; Champion GD Agents Actions Suppl; 1988; 24():121-33. PubMed ID: 3055875 [No Abstract] [Full Text] [Related]